Morgan Stanley 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-08 4:31 pm Sale | 2023-11-30 | 13G | Amicus Therapeutics, Inc. FOLD | MORGAN STANLEY MS | 12,303,701 4.200% | -5,281,315 (-30.03%) | Filing |
| 2023-02-08 12:42 pm Purchase | 2022-12-30 | 13G | Amicus Therapeutics, Inc. FOLD | MORGAN STANLEY MS | 17,585,016 6.300% | 4,847,359 (+38.06%) | Filing |
| 2021-02-10 12:27 pm Sale | 2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD | MORGAN STANLEY MS | 12,737,657 4.900% | -1,925,794 (-13.13%) | Filing |
| 2020-10-22 4:11 pm Purchase | 2020-10-15 | 13G | Amicus Therapeutics, Inc. FOLD | MORGAN STANLEY MS | 14,663,451 5.700% | 12,982,050 (+772.10%) | Filing |
| 2020-06-09 4:46 pm Sale | 2020-05-29 | 13G | Amicus Therapeutics, Inc. FOLD | MORGAN STANLEY MS | 1,681,401 0.700% | -11,231,264 (-86.98%) | Filing |